Waisse Waissi

Faculté De Médecine Lyon Est
Lyon, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications

Twenty-five years survival of primary central nervous system lymphomas treated with the C5R regimen.

Twenty-five years survival of primary central nervous system lymphomas treated with the C5R regimen.

Journal: European journal of cancer (Oxford, England : 1990)
Published: June 17, 2026

Breast cancer tumour board: Which patients are eligible for radiotherapy de-escalation or omission?

Breast cancer tumour board: Which patients are eligible for radiotherapy de-escalation or omission?

Journal: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
Published: June 26, 2025

Assessing targetable NTRK1/2/3 fusions in mesenchymal tumors via whole-exome RNA sequencing.

Assessing targetable NTRK1/2/3 fusions in mesenchymal tumors via whole-exome RNA sequencing.

Journal: ESMO open
Published: June 04, 2025

Clinical and biological factors associated with response to immune checkpoint inhibitors in advanced sarcomas: IMPRESARC, a French retrospective multicenter cohort study.

Clinical and biological factors associated with response to immune checkpoint inhibitors in advanced sarcomas: IMPRESARC, a French retrospective multicenter cohort study.

Journal: Cancer
Published: May 27, 2025

Exploring treatment complexity in maxillary ameloblastoma: A case study on the efficacy of radiotherapy with transcriptomic and literature insights.

Exploring treatment complexity in maxillary ameloblastoma: A case study on the efficacy of radiotherapy with transcriptomic and literature insights.

Journal: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
Published: August 18, 2024

Complications and Risk Factors in Patients with Soft Tissue Sarcoma of the Extremities Treated with Radiotherapy.

Complications and Risk Factors in Patients with Soft Tissue Sarcoma of the Extremities Treated with Radiotherapy.

Journal: Cancers
Published: April 27, 2024

Factors Influencing Long-Term Local Recurrence, Distant Metastasis, and Survival in Patients with Soft Tissue Sarcoma of the Extremities Treated with Radiotherapy.

Factors Influencing Long-Term Local Recurrence, Distant Metastasis, and Survival in Patients with Soft Tissue Sarcoma of the Extremities Treated with Radiotherapy.

Journal: Cancers
Published: April 21, 2024

Optimizing lung cancer radiation therapy: A systematic review of multifactorial risk assessment for radiation-induced lung toxicity.

Optimizing lung cancer radiation therapy: A systematic review of multifactorial risk assessment for radiation-induced lung toxicity.

Journal: Cancer treatment reviews
Published: October 09, 2023

Prognostic Factors in Extremity Soft Tissue Sarcomas Treated with Radiotherapy: Systematic Review of the Literature.

Prognostic Factors in Extremity Soft Tissue Sarcomas Treated with Radiotherapy: Systematic Review of the Literature.

Journal: Cancers
Published: August 12, 2023

Stereotactic body radiation therapy in unresectable stage III non-small cell lung cancer: A systematic review.

Stereotactic body radiation therapy in unresectable stage III non-small cell lung cancer: A systematic review.

Journal: Cancer treatment reviews
Published: January 30, 2023

Immunotherapy for Soft Tissue Sarcomas: Anti-PD1/PDL1 and Beyond.

Immunotherapy for Soft Tissue Sarcomas: Anti-PD1/PDL1 and Beyond.

Journal: Cancers
Published: January 30, 2023

Efficacy and Safety of Adjuvant Radiotherapy in Re-excised Soft-tissue Sarcoma After Unplanned Resection.

Efficacy and Safety of Adjuvant Radiotherapy in Re-excised Soft-tissue Sarcoma After Unplanned Resection.

Journal: The oncologist
Published: November 07, 2022
Showing 1-12 of 26

Last Updated: 09/26/2026